Acalabrutinib Versus Investigator’s Choice in Relapsed/Refractory Chronic Lymphocytic Leukemia: Final ASCEND Trial Results
暂无分享，去创建一个
Á. Illés | M. Šimkovič | P. Ghia | A. Pluta | S. Dolan | W. Jurczak | D. Lysák | I. Kriachok | J. de la Serna | G. Musuraca | M. Wach | P. Campbell | E. Avery | M. Wang | Jae Hoon Lee | G. Usenko | A. Jacob | T. Yu